01 /
关于 LLY
Large-cap biopharma exposure driven by diabetes, obesity, and specialty-drug leadership.
股票LLY tracks the value of shares in Eli Lilly and Company, a global pharmaceutical firm focused on developing treatments for diabetes, obesity, oncology, and immunology, with recent growth driven by demand for GLP-1 based therapies. The stock is widely used as a large-cap biopharma benchmark tied to innovation in metabolic disease and specialty therapeutics.
- 跟踪标的
- NYSE:LLY ↗
02 /
价格走势
LLY · Trade XYZ
返回市场© Hyperhub
